logo

For the Inventor, By the Inventor

St. George, UT, United States of America

Lynda Wallenfels

This inventor holds 10 USPTO granted patents. Top assignee: Heska Corporation. Active years: 1997-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lynda Wallenfels. Retrieved from https://idiyas.com/inventor/lynda-wallenfels

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 80.0

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 42(Granted Patents)


Location History:

  • Ft. Collins, CO (US) (1997 - 1999)
  • St. George, UT (US) (1998 - 2009)

Company Filing History:

goldMedal10 out of 177 
 
Heska Corporation
 patents

Years Active: 1997-2009

Loading Chart...
10 patents (USPTO):Explore Patents
1. 7629446 - Nucleic acid molecules encoding a novel ectoparasite saliva protein (2009-12-08),
2. 7166693 - Ectoparasite saliva proteins (2007-01-23),
3. 6576238 - Ectoparasite saliva proteins and apparatus to collect such proteins (2003-06-10),
4. 6485968 - Ectoparasite saliva proteins and apparatus to collect such proteins (2002-11-26),
5. 5932470 - Ectoparasite saliva proteins and apparatus to collect such proteins (1999-08-03),
6. 5927230 - Ectoparasite saliva proteins and apparatus to collect such proteins (1999-07-27),
7. 5849262 - Bioassay system for arthropods which elastically attaches to an animal (1998-12-15),
8. 5840695 - Ectoparasite saliva proteins and apparatus to collect such proteins (1998-11-24),
9. 5795862 - Ectoparasite saliva proteins and apparatus to collect such proteins (1998-08-18),
10. 5646115 - Ectoparasite saliva proteins and apparatus to collect such proteins (1997-07-08),

Title: Lynda Wallenfels: Innovator in Ectoparasite Saliva Proteins

Introduction

Lynda Wallenfels is a prominent inventor based in St. George, UT (US). She has made significant contributions to the field of veterinary medicine, particularly in the area of allergic dermatitis in animals. With a total of 10 patents to her name, Wallenfels has established herself as a leading figure in her domain.

Latest Patents

Among her latest patents is a groundbreaking invention related to nucleic acid molecules encoding a novel ectoparasite saliva protein. This invention is directed towards isolating ectoparasite saliva proteins and developing methods for detecting and treating allergic dermatitis in animals. The invention includes a saliva protein collection apparatus designed to collect ectoparasite saliva proteins that are substantially free of contaminating material. Additionally, it encompasses nucleic acid molecules with sequences that encode these proteins and antibodies raised against them. The methods outlined in her patents aim to identify animals that are susceptible to or already have allergic dermatitis. Furthermore, therapeutic compositions comprising these proteins are included, which can be used to treat affected animals.

Career Highlights

Wallenfels has been associated with Heska Corporation, where she has contributed her expertise in the development of innovative solutions for animal health. Her work has been instrumental in advancing the understanding and treatment of allergic conditions in pets.

Collaborations

Some of her notable coworkers include Glenn R Frank and Shirley Wu Hunter, who have collaborated with her on various projects related to her patents and innovations.

Conclusion

Lynda Wallenfels is a trailblazer in the field of veterinary medicine, particularly in the study of ectoparasite saliva proteins and their implications for allergic dermatitis in animals. Her innovative patents and contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…